Juno is a clinical-stage company that brings together three of the world’s leading cancer centers – Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children’s Research Institute – in unique partnership to advance a broad pipeline of breakthrough immunotherapies. With one of the largest ever Series A investments for a biotech startup, Juno will build on the foundation of novel immunotherapies to develop two distinct and complementary platforms – CARs and TCRs.

Tianjin Baiteng Productivity Promotion Center Co., Ltd., established on 2010-11-15, Business scope includes scientific and technological information exchange,technical consulting;Intellectual property information consultation,Serve,Promotion and Transfer.(Involving countries with special monopoly regulations,Execute according to regulations;involving industry licensing,Operate with a license or approval document)

Batu Biologics is a preclinical biopharmaceutical company focusing on developing and commercializing allogeneic cell therepies in the area of immune modulation. Our products are centered around the idea of creating or breaking immune tolerance. The company is currently in the preclinical stages of drug development for its two flagship products: Immstem and Vallovax. Batu Biologics has filed two provisional patents in the field of cancer immunotherapy and plans to significantly expand its IP

The National Institute of Advanced Industrial Science and Technology (AIST), led by President Chubachi, is a public research institution funded by the Japanese government to a large extent. The present AIST is a rather new research organization established in 2001. However, AIST and its predecessor organizations have been contributing to society through continuous advancement in technologies and support to Japanese industries since 1882. Headquarters of AIST are located in Tsukuba and Tokyo. AIST has over 40 autonomous research units in various innovative research fields, and the units are located at ten research bases and several sites (smaller than research bases) of AIST all over Japan. About 2300 researchers (about 2000 with tenure: about 80 from abroad) and a few thousands of visiting scientists, post-doctoral fellows, and students from home and abroad are working at AIST. About 650 permanent administrative personnel and many temporary staff support research works of AIST.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Hangzhou Glory Star Pharmaceutical Co., Ltd., established on 2018-07-05, Business scope includes licensed projects:Drug Wholesale;Class III medical device business;Import and export agency;Import and export;Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Human stem cell technology development and application;Development of Human Gene Diagnosis and Therapy Technology;Health Consulting Services(Does not include medical services);Cosmetics Retail;Cosmetics Wholesale;Instrument sales;General merchandise sales;Experimental analysis instrument sales;Smart Instrument Sales;Specialty Chemicals Sales(Free of Hazardous Chemicals);Sales of Class II Medical Devices;Research and development of biopesticide technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Venture Capital;Socioeconomic Advisory Services;Information Consulting Service(Not including licensing information consulting services)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Instytut Zootechniki conducts scientific research and development works in the field of animal production.

Abreos Biosciences develops lateral flow assays that measure the activity of high-value biologics. Its simple devices can be used for quality assurance, pharmacokinetic monitoring, and authentication in field, forensic, or point of care settings. We deliver value by enhancing brand protection, improving patients’ outcomes, and enabling rapid authentication for counterfeit prevention and end-user confidence. The company was founded in 2013 and headquartered in San Diego, California.

Wuhan Ruiqi Bioengineering Co., Ltd., established on 2016-01-06, Business scope includes biotechnology development;laboratory reagent(Does not contain dangerous goods and drugs)research and development,Production,Wholesale and retail;Import and export,Technology Import and Export,Agent import and export(Does not contain goods or technologies that are prohibited or restricted from import and export by the state);one type,Class II,Three types of medical device research and development,Production,wholesale and retail,lease,Install,Maintenance and technical consultation;Technology development in the field of medical technology,technical consulting;Production of inspection and testing equipment,wholesale and retail;Inspection and testing service;Instrumentation,Production of electronic components,wholesale and retail;Technology Development of Mechatronics Products,wholesale and retail,Install;Technology development of computer hardware and software,technology transfer,technical consulting,Technical Services;Health Advisory(Does not include diagnosis and treatment).(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)